Vitamin D, arterial hypertension & cerebrovascular disease

Autor: Kienreich, K., Grübler, M., Tomaschitz, A., Johannes Schmid, Verheyen, N., Rutters, F., Dekker, J. M., Pilz, S.
Přispěvatelé: Epidemiology and Data Science, EMGO - Lifestyle, overweight and diabetes
Rok vydání: 2013
Předmět:
Zdroj: Indian Journal of Medical Research, 137(4), 669-679. Medknow Publications and Media Pvt. Ltd
Scopus-Elsevier
Kienreich, K, Grubler, M, Tomaschitz, A, Schmid, J, Verheyen, N, Rutters, F, Dekker, J M & Pilz, S 2013, ' Vitamin D, arterial hypertension & cerebrovascular disease ', Indian Journal of Medical Research, vol. 137, no. 4, pp. 669-679 .
The Indian Journal of Medical Research
ISSN: 0971-5916
Popis: Vitamin D is mainly derived from endogenous ultraviolet-B induced vitamin D synthesis in the skin, and the current high prevalence of vitamin D deficiency can, therefore, largely be attributed to lifestyle related low sunlight exposure. Regulation of bone and mineral metabolism is a classic vitamin D effect, but the identification of the vitamin D receptor (VDR) in almost all human cells suggests a role for vitamin D also in extra-skeletal diseases. Experimental studies demonstrated several antihypertensive and vascular protective effects of vitamin D, such as suppression of the renin angiotensin aldosterone system, beneficial modulation of classic cardiovascular risk factors, and anti-atherosclerotic properties including improvements of endothelial function. Additional neuroprotective actions of vitamin D have also been reported. In line with this, epidemiological studies have largely shown that vitamin D deficiency is an independent risk factor for arterial hypertension and strokes. Data from randomized controlled trials (RCTs) are, however, limited and less promising, with currently no confirmation that vitamin D reduces stroke incidence. Whereas some RCTs suggest that vitamin D supplementation might modestly reduce blood pressure, this has not been consistently observed in all studies. It is, therefore, premature to recommend vitamin D supplementation for the prevention and treatment of arterial hypertension and stroke. Nevertheless, the fact that patients with arterial hypertension and cerebrovascular disease are at a relatively high risk of vitamin D deficiency, and therewith associated musculoskeletal diseases can serve as a rationale for the evaluation, prevention and treatment of vitamin D deficiency in these patients.
Databáze: OpenAIRE
Externí odkaz: